This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Key Reasons Why UPS Stock Should Grace Your Portfolio Now
by Zacks Equity Research
The surge in e-commerce growth in the current scenario is a huge boon for UPS.
Wall Street Surges on COVID-19 Vaccine Approval
by Zacks Equity Research
Wall Street Surges on COVID-19 Vaccine Approval.
6 Consumer Discretionary ETFs Riding on Holiday Fervor
by Sweta Killa
U.S. consumers grew more confident in the economy in early December on the prospects of a vaccine, which has bolstered the holiday mood.
Historic Day for Pfizer (PFE), Covid-19 Vaccine
by Mark Vickery
With more than 180K daily reported cases as of yesterday, with more than 109K hospitalizations and nearly 1500 deaths on Sunday alone, this vaccine availability is not just historic, it's momentous.
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Occidental Petroleum, Devon Energy, Diamondback Energy, Baker Hughes and Marathon Oil
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Occidental Petroleum, Devon Energy, Diamondback Energy, Baker Hughes and Marathon Oil
Stocks Decline modestly, but Vaccine Optimism Promises a New Rally
by David Borun
A massive rollout of vaccine distribution is the best hope yet for a "return to normal."
ETFs to Win & Lose From the Surge in Oil Price
by Sweta Killa
Oil price has been on a surge in recent months buoyed by solid development on the COVID-19 vaccine front.
Biotech ETF (SBIO) Hits a New 52-Week High
by Sweta Killa
This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?
Merck (MRK) Keytruda Gets CHMP Nod for First-Line Colon Cancer
by Zacks Equity Research
Merck's (MRK) regulatory application seeking label expansion of Keytruda as first-line treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer gets positive CHMP opinion.
5 High Earnings Yield Bets Amid an Uncertain Santa Rally
by Rimmi Singhi
Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback.
COVID-19 Vaccine Race Heats Up as Pfizer Gets Emergency Nod
by Kinjel Shah
FDA grants emergency use approval to Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate.
5 Energy ETFs Making the Most of the Oil Rally
by Sweta Killa
After registering the best month ever, the energy sector continued its bullish trend on vaccine optimism,
Producer Price Index in Line With Expectations
by Zacks Equity Research
Producer Price Index in Line With Expectations
Glaxo (GSK)/Sanofi Delay Study on Coronavirus Vaccine Candidate
by Zacks Equity Research
Glaxo (GSK)/Sanofi's (SNY) adjuvanted recombinant COVID-19 vaccine candidate shows low immune response in older adults in phase I/II study. The companies will develop the vaccine with an improved antigen formulation.
Government Shutdown Looms, Vaccine Nears Passage
by Mark Vickery
If the government shuts down, talks cease on pandemic relief allotments, including Pandemic Unemployment Assistance (PUA), which is due to expire the day after Christmas.
Pfizer/BioNTech COVID-19 Vaccine Gets FDA Panel's Backing
by Zacks Equity Research
An FDA panel recommends granting approval for emergency use of Pfizer's (PFE)/BioNTech's (BNTX) COVID-19 vaccine
Moderna (MRNA) Starts COVID-19 Vaccine Study in Adolescents
by Zacks Equity Research
Moderna (MRNA) initiates development of its coronavirus vaccine candidate, mRNA-1273, in adolescent patients in a phase II/III study.
Pharma Stock Roundup: FDA Panel's Nod to PFE/BNTX Coronavirus Vaccine, Other Updates
by Kinjel Shah
An FDA panel recommends granting approval for emergency use of Pfizer's (PFE) COVID-19 vaccine. Glaxo (GSK)/Sanofi (SNY) COVID-19 vaccine plan delays.
5 Bank Stocks to Gain Amid Potential Economic Recovery
by Zacks Equity Research
Low mortgage rates, falling provisions, vaccine news and hopes of stimulus aid bode well for banks, making it wise to invest in names like BOK Financial (BOKF) and First Hawaiian (FHB).
Energy Sector Up 21% in Past 3 Months: Will the Rally Last?
by Nilanjan Choudhury
Occidental Petroleum (OXY) is the top performing energy stock within the S&P 500 in the past 3 months with a gain of 108.6% while Devon Energy (DVN) is the next best name on the list, soaring 84.8%.
3 Online Education Stocks to Buy as Coronavirus Fears Rise
by Ritujay Ghosh
The COVID-19 pandemic has completely changed the concept of learning, which has led to the popularity of online education stocks like American Public Education, Inc. (APEI), GP Strategies Corporation (GPX) and Lincoln Educational Services Corporation (LINC).
Bull of the Day: Quidel (QDEL)
by Kevin Cook
COVID and influenza A+B tests have launched sales and profit estimates triple-digits into 2021
Inflation to Pick Up in 2021: Bet on TIPS ETFs
by Sweta Killa
The expectation for an uptick in inflation has led to investors' flocking to Treasury Inflation Protected Securities (TIPS) ETFs.
Emerging Markets Hit Record High: 5 Top-Performing ETFs YTD
by Sweta Killa
While many emerging market ETFs have been performing remarkably well, we highlight five funds that are leading the space from a year-to-date basis.
Pfizer/BioNTech COVID-19 Vaccine Raises New Safety Concerns
by Zacks Equity Research
The Bell's palsy related side-effects are not alarming enough to preclude FDA from granting emergency approval to Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine.